nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—Protein Kinase Inhibitors—Sunitinib—pancreatic cancer	0.324	1	CiPCiCtD
Pazopanib—kidney cancer—pancreatic cancer	0.218	1	CtDrD
Pazopanib—KDR—pancreatic cancer	0.0973	1	CbGaD
Pazopanib—PIP4K2C—Erlotinib—pancreatic cancer	0.0188	0.0757	CbGbCtD
Pazopanib—ITK—Sunitinib—pancreatic cancer	0.0171	0.069	CbGbCtD
Pazopanib—RIOK2—Sunitinib—pancreatic cancer	0.0171	0.069	CbGbCtD
Pazopanib—AURKC—Erlotinib—pancreatic cancer	0.0149	0.0601	CbGbCtD
Pazopanib—STK16—Sunitinib—pancreatic cancer	0.0124	0.0499	CbGbCtD
Pazopanib—AURKC—Sunitinib—pancreatic cancer	0.00982	0.0396	CbGbCtD
Pazopanib—FLT1—Sunitinib—pancreatic cancer	0.00982	0.0396	CbGbCtD
Pazopanib—STK10—Erlotinib—pancreatic cancer	0.00856	0.0345	CbGbCtD
Pazopanib—PLK4—Sunitinib—pancreatic cancer	0.00821	0.0331	CbGbCtD
Pazopanib—FGFR1—Sunitinib—pancreatic cancer	0.00821	0.0331	CbGbCtD
Pazopanib—FLT4—Sunitinib—pancreatic cancer	0.00821	0.0331	CbGbCtD
Pazopanib—FGFR2—Sunitinib—pancreatic cancer	0.00821	0.0331	CbGbCtD
Pazopanib—TAOK3—Sunitinib—pancreatic cancer	0.00821	0.0331	CbGbCtD
Pazopanib—MAP2K5—Erlotinib—pancreatic cancer	0.00779	0.0314	CbGbCtD
Pazopanib—MAP3K19—Erlotinib—pancreatic cancer	0.00716	0.0289	CbGbCtD
Pazopanib—KDR—Sunitinib—pancreatic cancer	0.0071	0.0286	CbGbCtD
Pazopanib—MAP3K2—Sunitinib—pancreatic cancer	0.0071	0.0286	CbGbCtD
Pazopanib—EPHB6—Sunitinib—pancreatic cancer	0.00627	0.0253	CbGbCtD
Pazopanib—KIT—Sunitinib—pancreatic cancer	0.00564	0.0228	CbGbCtD
Pazopanib—CSF1R—Sunitinib—pancreatic cancer	0.00564	0.0228	CbGbCtD
Pazopanib—PDGFRA—Sunitinib—pancreatic cancer	0.00564	0.0228	CbGbCtD
Pazopanib—STK10—Sunitinib—pancreatic cancer	0.00564	0.0228	CbGbCtD
Pazopanib—MAP2K5—Sunitinib—pancreatic cancer	0.00513	0.0207	CbGbCtD
Pazopanib—PDGFRB—Sunitinib—pancreatic cancer	0.00513	0.0207	CbGbCtD
Pazopanib—MAP3K19—Sunitinib—pancreatic cancer	0.00472	0.019	CbGbCtD
Pazopanib—UGT1A1—Erlotinib—pancreatic cancer	0.00257	0.0104	CbGbCtD
Pazopanib—UGT1A1—Irinotecan—pancreatic cancer	0.00232	0.00937	CbGbCtD
Pazopanib—ABCG2—Tamoxifen—pancreatic cancer	0.00166	0.00671	CbGbCtD
Pazopanib—SLCO1B1—Irinotecan—pancreatic cancer	0.00161	0.00648	CbGbCtD
Pazopanib—ABCG2—Erlotinib—pancreatic cancer	0.00141	0.0057	CbGbCtD
Pazopanib—ABCG2—Irinotecan—pancreatic cancer	0.00128	0.00515	CbGbCtD
Pazopanib—ABCG2—Fluorouracil—pancreatic cancer	0.00122	0.00494	CbGbCtD
Pazopanib—FLT1—umbilical vein—pancreatic cancer	0.00108	0.0899	CbGeAlD
Pazopanib—ABCG2—Docetaxel—pancreatic cancer	0.000935	0.00378	CbGbCtD
Pazopanib—ABCG2—Sunitinib—pancreatic cancer	0.000931	0.00376	CbGbCtD
Pazopanib—KDR—umbilical vein—pancreatic cancer	0.000913	0.076	CbGeAlD
Pazopanib—CYP2C8—Tamoxifen—pancreatic cancer	0.000885	0.00357	CbGbCtD
Pazopanib—CYP1A2—Dacarbazine—pancreatic cancer	0.000862	0.00348	CbGbCtD
Pazopanib—MAP3K9—islet of Langerhans—pancreatic cancer	0.000811	0.0675	CbGeAlD
Pazopanib—CYP2C8—Erlotinib—pancreatic cancer	0.000753	0.00304	CbGbCtD
Pazopanib—ABCG2—Doxorubicin—pancreatic cancer	0.000697	0.00281	CbGbCtD
Pazopanib—CYP1A2—Tamoxifen—pancreatic cancer	0.000685	0.00277	CbGbCtD
Pazopanib—CYP2C8—Fluorouracil—pancreatic cancer	0.000653	0.00263	CbGbCtD
Pazopanib—ABCB1—Tamoxifen—pancreatic cancer	0.000599	0.00242	CbGbCtD
Pazopanib—CYP1A2—Erlotinib—pancreatic cancer	0.000583	0.00235	CbGbCtD
Pazopanib—SH2B3—islet of Langerhans—pancreatic cancer	0.000574	0.0477	CbGeAlD
Pazopanib—MAP3K9—pancreas—pancreatic cancer	0.00057	0.0475	CbGeAlD
Pazopanib—CYP2D6—Tamoxifen—pancreatic cancer	0.000565	0.00228	CbGbCtD
Pazopanib—ABCB1—Gemcitabine—pancreatic cancer	0.000516	0.00208	CbGbCtD
Pazopanib—ABCB1—Erlotinib—pancreatic cancer	0.00051	0.00206	CbGbCtD
Pazopanib—CYP1A2—Fluorouracil—pancreatic cancer	0.000505	0.00204	CbGbCtD
Pazopanib—STK16—islet of Langerhans—pancreatic cancer	0.000488	0.0406	CbGeAlD
Pazopanib—MAP3K9—digestive system—pancreatic cancer	0.000487	0.0405	CbGeAlD
Pazopanib—CYP2D6—Erlotinib—pancreatic cancer	0.00048	0.00194	CbGbCtD
Pazopanib—ABCB1—Irinotecan—pancreatic cancer	0.00046	0.00186	CbGbCtD
Pazopanib—PI4KB—islet of Langerhans—pancreatic cancer	0.000425	0.0353	CbGeAlD
Pazopanib—PDGFRA—gall bladder—pancreatic cancer	0.000416	0.0346	CbGeAlD
Pazopanib—PLK4—Topotecan—Irinotecan—pancreatic cancer	0.000412	0.525	CbGdCrCtD
Pazopanib—SH2B3—pancreas—pancreatic cancer	0.000403	0.0335	CbGeAlD
Pazopanib—PIP4K2C—islet of Langerhans—pancreatic cancer	0.000373	0.031	CbGeAlD
Pazopanib—CYP3A4—Tamoxifen—pancreatic cancer	0.000359	0.00145	CbGbCtD
Pazopanib—ABCB1—Docetaxel—pancreatic cancer	0.000337	0.00136	CbGbCtD
Pazopanib—ABCB1—Sunitinib—pancreatic cancer	0.000336	0.00135	CbGbCtD
Pazopanib—KIT—gall bladder—pancreatic cancer	0.000333	0.0277	CbGeAlD
Pazopanib—PDGFRB—gall bladder—pancreatic cancer	0.000325	0.027	CbGeAlD
Pazopanib—CYP3A4—Erlotinib—pancreatic cancer	0.000305	0.00123	CbGbCtD
Pazopanib—PI4KB—pancreas—pancreatic cancer	0.000299	0.0248	CbGeAlD
Pazopanib—STK16—digestive system—pancreatic cancer	0.000293	0.0244	CbGeAlD
Pazopanib—FLT1—islet of Langerhans—pancreatic cancer	0.000291	0.0242	CbGeAlD
Pazopanib—EPHB6—islet of Langerhans—pancreatic cancer	0.000288	0.024	CbGeAlD
Pazopanib—CYP3A4—Irinotecan—pancreatic cancer	0.000276	0.00111	CbGbCtD
Pazopanib—TAOK3—islet of Langerhans—pancreatic cancer	0.000275	0.0229	CbGeAlD
Pazopanib—PIP4K2C—pancreas—pancreatic cancer	0.000262	0.0218	CbGeAlD
Pazopanib—ABCB1—Doxorubicin—pancreatic cancer	0.000251	0.00101	CbGbCtD
Pazopanib—CYP2D6—Doxorubicin—pancreatic cancer	0.000237	0.000956	CbGbCtD
Pazopanib—PDGFRB—islet of Langerhans—pancreatic cancer	0.000213	0.0177	CbGeAlD
Pazopanib—FLT1—pancreas—pancreatic cancer	0.000205	0.017	CbGeAlD
Pazopanib—CYP3A4—Docetaxel—pancreatic cancer	0.000202	0.000816	CbGbCtD
Pazopanib—CYP3A4—Sunitinib—pancreatic cancer	0.000201	0.000812	CbGbCtD
Pazopanib—FGF1—digestive system—pancreatic cancer	0.0002	0.0166	CbGeAlD
Pazopanib—TAOK3—pancreas—pancreatic cancer	0.000193	0.0161	CbGeAlD
Pazopanib—FGFR2—digestive system—pancreatic cancer	0.000189	0.0157	CbGeAlD
Pazopanib—FLT1—digestive system—pancreatic cancer	0.000175	0.0145	CbGeAlD
Pazopanib—STK10—digestive system—pancreatic cancer	0.000166	0.0138	CbGeAlD
Pazopanib—TAOK3—digestive system—pancreatic cancer	0.000165	0.0137	CbGeAlD
Pazopanib—PDGFRA—digestive system—pancreatic cancer	0.000164	0.0136	CbGeAlD
Pazopanib—UGT1A1—digestive system—pancreatic cancer	0.000156	0.013	CbGeAlD
Pazopanib—KIT—pancreas—pancreatic cancer	0.000153	0.0128	CbGeAlD
Pazopanib—CYP3A4—Doxorubicin—pancreatic cancer	0.000151	0.000608	CbGbCtD
Pazopanib—PDGFRB—pancreas—pancreatic cancer	0.00015	0.0125	CbGeAlD
Pazopanib—KDR—digestive system—pancreatic cancer	0.000148	0.0123	CbGeAlD
Pazopanib—CSF1R—digestive system—pancreatic cancer	0.000144	0.012	CbGeAlD
Pazopanib—KIT—digestive system—pancreatic cancer	0.000131	0.0109	CbGeAlD
Pazopanib—SLCO1B1—digestive system—pancreatic cancer	0.00013	0.0108	CbGeAlD
Pazopanib—PDGFRB—digestive system—pancreatic cancer	0.000128	0.0106	CbGeAlD
Pazopanib—PLK4—Idarubicin—Epirubicin—pancreatic cancer	9.68e-05	0.123	CbGdCrCtD
Pazopanib—PLK4—Doxorubicin—Epirubicin—pancreatic cancer	9.68e-05	0.123	CbGdCrCtD
Pazopanib—PLK4—Idarubicin—Doxorubicin—pancreatic cancer	8.96e-05	0.114	CbGdCrCtD
Pazopanib—PLK4—Epirubicin—Doxorubicin—pancreatic cancer	8.96e-05	0.114	CbGdCrCtD
Pazopanib—CYP1A2—digestive system—pancreatic cancer	6.92e-05	0.00576	CbGeAlD
Pazopanib—ABCB1—islet of Langerhans—pancreatic cancer	5.91e-05	0.00491	CbGeAlD
Pazopanib—CYP3A4—digestive system—pancreatic cancer	5.01e-05	0.00417	CbGeAlD
Pazopanib—CYP2D6—digestive system—pancreatic cancer	4.93e-05	0.0041	CbGeAlD
Pazopanib—ABCB1—pancreas—pancreatic cancer	4.15e-05	0.00345	CbGeAlD
Pazopanib—ABCB1—digestive system—pancreatic cancer	3.55e-05	0.00295	CbGeAlD
Pazopanib—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	1.94e-05	0.000364	CcSEcCtD
Pazopanib—Dyspnoea—Fluorouracil—pancreatic cancer	1.94e-05	0.000364	CcSEcCtD
Pazopanib—Mental disorder—Docetaxel—pancreatic cancer	1.94e-05	0.000363	CcSEcCtD
Pazopanib—Somnolence—Fluorouracil—pancreatic cancer	1.94e-05	0.000363	CcSEcCtD
Pazopanib—Nasopharyngitis—Epirubicin—pancreatic cancer	1.93e-05	0.000362	CcSEcCtD
Pazopanib—Face oedema—Doxorubicin—pancreatic cancer	1.93e-05	0.000361	CcSEcCtD
Pazopanib—Malnutrition—Docetaxel—pancreatic cancer	1.93e-05	0.000361	CcSEcCtD
Pazopanib—Erythema—Docetaxel—pancreatic cancer	1.93e-05	0.000361	CcSEcCtD
Pazopanib—Decreased appetite—Gemcitabine—pancreatic cancer	1.93e-05	0.000361	CcSEcCtD
Pazopanib—Dyspepsia—Fluorouracil—pancreatic cancer	1.92e-05	0.000359	CcSEcCtD
Pazopanib—Nausea—Tamoxifen—pancreatic cancer	1.91e-05	0.000359	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	1.91e-05	0.000358	CcSEcCtD
Pazopanib—Fatigue—Gemcitabine—pancreatic cancer	1.91e-05	0.000358	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	1.9e-05	0.000357	CcSEcCtD
Pazopanib—Pain—Gemcitabine—pancreatic cancer	1.89e-05	0.000355	CcSEcCtD
Pazopanib—Nausea—Erlotinib—pancreatic cancer	1.89e-05	0.000355	CcSEcCtD
Pazopanib—Decreased appetite—Fluorouracil—pancreatic cancer	1.89e-05	0.000355	CcSEcCtD
Pazopanib—Diarrhoea—Sunitinib—pancreatic cancer	1.89e-05	0.000354	CcSEcCtD
Pazopanib—Dysgeusia—Docetaxel—pancreatic cancer	1.89e-05	0.000353	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	1.88e-05	0.000352	CcSEcCtD
Pazopanib—Abdominal distension—Epirubicin—pancreatic cancer	1.88e-05	0.000352	CcSEcCtD
Pazopanib—Blood creatinine increased—Doxorubicin—pancreatic cancer	1.87e-05	0.00035	CcSEcCtD
Pazopanib—Pain—Fluorouracil—pancreatic cancer	1.86e-05	0.000349	CcSEcCtD
Pazopanib—Gastrointestinal pain—Irinotecan—pancreatic cancer	1.86e-05	0.000348	CcSEcCtD
Pazopanib—Dehydration—Doxorubicin—pancreatic cancer	1.86e-05	0.000348	CcSEcCtD
Pazopanib—Muscle spasms—Docetaxel—pancreatic cancer	1.85e-05	0.000347	CcSEcCtD
Pazopanib—Liver function test abnormal—Doxorubicin—pancreatic cancer	1.84e-05	0.000345	CcSEcCtD
Pazopanib—Dry skin—Doxorubicin—pancreatic cancer	1.83e-05	0.000343	CcSEcCtD
Pazopanib—Pancreatitis—Epirubicin—pancreatic cancer	1.83e-05	0.000343	CcSEcCtD
Pazopanib—Dizziness—Sunitinib—pancreatic cancer	1.83e-05	0.000342	CcSEcCtD
Pazopanib—Abdominal pain upper—Doxorubicin—pancreatic cancer	1.82e-05	0.000342	CcSEcCtD
Pazopanib—Breast disorder—Doxorubicin—pancreatic cancer	1.8e-05	0.000338	CcSEcCtD
Pazopanib—Abdominal pain—Irinotecan—pancreatic cancer	1.8e-05	0.000337	CcSEcCtD
Pazopanib—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	1.8e-05	0.000337	CcSEcCtD
Pazopanib—Nasopharyngitis—Doxorubicin—pancreatic cancer	1.78e-05	0.000335	CcSEcCtD
Pazopanib—Anaemia—Docetaxel—pancreatic cancer	1.78e-05	0.000334	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	1.76e-05	0.00033	CcSEcCtD
Pazopanib—Vomiting—Sunitinib—pancreatic cancer	1.76e-05	0.000329	CcSEcCtD
Pazopanib—Neutropenia—Epirubicin—pancreatic cancer	1.74e-05	0.000327	CcSEcCtD
Pazopanib—Rash—Sunitinib—pancreatic cancer	1.74e-05	0.000326	CcSEcCtD
Pazopanib—Dermatitis—Sunitinib—pancreatic cancer	1.74e-05	0.000326	CcSEcCtD
Pazopanib—Abdominal distension—Doxorubicin—pancreatic cancer	1.74e-05	0.000325	CcSEcCtD
Pazopanib—Headache—Sunitinib—pancreatic cancer	1.73e-05	0.000324	CcSEcCtD
Pazopanib—Syncope—Docetaxel—pancreatic cancer	1.73e-05	0.000324	CcSEcCtD
Pazopanib—Leukopenia—Docetaxel—pancreatic cancer	1.72e-05	0.000323	CcSEcCtD
Pazopanib—Photosensitivity reaction—Epirubicin—pancreatic cancer	1.7e-05	0.000319	CcSEcCtD
Pazopanib—Loss of consciousness—Docetaxel—pancreatic cancer	1.69e-05	0.000317	CcSEcCtD
Pazopanib—Pancreatitis—Doxorubicin—pancreatic cancer	1.69e-05	0.000317	CcSEcCtD
Pazopanib—Weight decreased—Epirubicin—pancreatic cancer	1.69e-05	0.000316	CcSEcCtD
Pazopanib—Cough—Docetaxel—pancreatic cancer	1.68e-05	0.000315	CcSEcCtD
Pazopanib—Hypertension—Docetaxel—pancreatic cancer	1.66e-05	0.000312	CcSEcCtD
Pazopanib—Infestation NOS—Epirubicin—pancreatic cancer	1.66e-05	0.000312	CcSEcCtD
Pazopanib—Infestation—Epirubicin—pancreatic cancer	1.66e-05	0.000312	CcSEcCtD
Pazopanib—Chest pain—Docetaxel—pancreatic cancer	1.64e-05	0.000307	CcSEcCtD
Pazopanib—Arthralgia—Docetaxel—pancreatic cancer	1.64e-05	0.000307	CcSEcCtD
Pazopanib—Myalgia—Docetaxel—pancreatic cancer	1.64e-05	0.000307	CcSEcCtD
Pazopanib—Nausea—Sunitinib—pancreatic cancer	1.64e-05	0.000307	CcSEcCtD
Pazopanib—Asthenia—Irinotecan—pancreatic cancer	1.63e-05	0.000306	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	1.63e-05	0.000305	CcSEcCtD
Pazopanib—Stomatitis—Epirubicin—pancreatic cancer	1.62e-05	0.000304	CcSEcCtD
Pazopanib—Jaundice—Epirubicin—pancreatic cancer	1.62e-05	0.000304	CcSEcCtD
Pazopanib—Neutropenia—Doxorubicin—pancreatic cancer	1.61e-05	0.000302	CcSEcCtD
Pazopanib—Dry mouth—Docetaxel—pancreatic cancer	1.6e-05	0.000301	CcSEcCtD
Pazopanib—Asthenia—Gemcitabine—pancreatic cancer	1.59e-05	0.000298	CcSEcCtD
Pazopanib—Haematuria—Epirubicin—pancreatic cancer	1.58e-05	0.000297	CcSEcCtD
Pazopanib—Photosensitivity reaction—Doxorubicin—pancreatic cancer	1.57e-05	0.000295	CcSEcCtD
Pazopanib—Hepatobiliary disease—Epirubicin—pancreatic cancer	1.57e-05	0.000295	CcSEcCtD
Pazopanib—Oedema—Docetaxel—pancreatic cancer	1.57e-05	0.000295	CcSEcCtD
Pazopanib—Epistaxis—Epirubicin—pancreatic cancer	1.57e-05	0.000294	CcSEcCtD
Pazopanib—Pruritus—Gemcitabine—pancreatic cancer	1.57e-05	0.000294	CcSEcCtD
Pazopanib—Infection—Docetaxel—pancreatic cancer	1.56e-05	0.000293	CcSEcCtD
Pazopanib—Weight decreased—Doxorubicin—pancreatic cancer	1.56e-05	0.000293	CcSEcCtD
Pazopanib—Diarrhoea—Irinotecan—pancreatic cancer	1.56e-05	0.000292	CcSEcCtD
Pazopanib—Shock—Docetaxel—pancreatic cancer	1.55e-05	0.00029	CcSEcCtD
Pazopanib—Nervous system disorder—Docetaxel—pancreatic cancer	1.54e-05	0.000289	CcSEcCtD
Pazopanib—Pruritus—Fluorouracil—pancreatic cancer	1.54e-05	0.000289	CcSEcCtD
Pazopanib—Thrombocytopenia—Docetaxel—pancreatic cancer	1.54e-05	0.000288	CcSEcCtD
Pazopanib—Infestation NOS—Doxorubicin—pancreatic cancer	1.54e-05	0.000288	CcSEcCtD
Pazopanib—Infestation—Doxorubicin—pancreatic cancer	1.54e-05	0.000288	CcSEcCtD
Pazopanib—Skin disorder—Docetaxel—pancreatic cancer	1.53e-05	0.000286	CcSEcCtD
Pazopanib—Bradycardia—Epirubicin—pancreatic cancer	1.52e-05	0.000285	CcSEcCtD
Pazopanib—Diarrhoea—Gemcitabine—pancreatic cancer	1.52e-05	0.000284	CcSEcCtD
Pazopanib—Dizziness—Irinotecan—pancreatic cancer	1.5e-05	0.000282	CcSEcCtD
Pazopanib—Haemoglobin—Epirubicin—pancreatic cancer	1.5e-05	0.000281	CcSEcCtD
Pazopanib—Jaundice—Doxorubicin—pancreatic cancer	1.5e-05	0.000281	CcSEcCtD
Pazopanib—Stomatitis—Doxorubicin—pancreatic cancer	1.5e-05	0.000281	CcSEcCtD
Pazopanib—Anorexia—Docetaxel—pancreatic cancer	1.5e-05	0.000281	CcSEcCtD
Pazopanib—Haemorrhage—Epirubicin—pancreatic cancer	1.49e-05	0.00028	CcSEcCtD
Pazopanib—Diarrhoea—Fluorouracil—pancreatic cancer	1.49e-05	0.000279	CcSEcCtD
Pazopanib—Hypoaesthesia—Epirubicin—pancreatic cancer	1.48e-05	0.000278	CcSEcCtD
Pazopanib—Urinary tract disorder—Epirubicin—pancreatic cancer	1.47e-05	0.000276	CcSEcCtD
Pazopanib—Oedema peripheral—Epirubicin—pancreatic cancer	1.47e-05	0.000276	CcSEcCtD
Pazopanib—Haematuria—Doxorubicin—pancreatic cancer	1.47e-05	0.000275	CcSEcCtD
Pazopanib—Connective tissue disorder—Epirubicin—pancreatic cancer	1.47e-05	0.000275	CcSEcCtD
Pazopanib—Urethral disorder—Epirubicin—pancreatic cancer	1.46e-05	0.000274	CcSEcCtD
Pazopanib—Hepatobiliary disease—Doxorubicin—pancreatic cancer	1.45e-05	0.000273	CcSEcCtD
Pazopanib—Epistaxis—Doxorubicin—pancreatic cancer	1.45e-05	0.000272	CcSEcCtD
Pazopanib—Vomiting—Irinotecan—pancreatic cancer	1.45e-05	0.000271	CcSEcCtD
Pazopanib—Dizziness—Fluorouracil—pancreatic cancer	1.44e-05	0.00027	CcSEcCtD
Pazopanib—Rash—Irinotecan—pancreatic cancer	1.43e-05	0.000269	CcSEcCtD
Pazopanib—Dermatitis—Irinotecan—pancreatic cancer	1.43e-05	0.000268	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	1.43e-05	0.000268	CcSEcCtD
Pazopanib—Headache—Irinotecan—pancreatic cancer	1.42e-05	0.000267	CcSEcCtD
Pazopanib—Insomnia—Docetaxel—pancreatic cancer	1.42e-05	0.000266	CcSEcCtD
Pazopanib—Paraesthesia—Docetaxel—pancreatic cancer	1.41e-05	0.000265	CcSEcCtD
Pazopanib—Vomiting—Gemcitabine—pancreatic cancer	1.41e-05	0.000264	CcSEcCtD
Pazopanib—Bradycardia—Doxorubicin—pancreatic cancer	1.41e-05	0.000263	CcSEcCtD
Pazopanib—Dyspnoea—Docetaxel—pancreatic cancer	1.4e-05	0.000263	CcSEcCtD
Pazopanib—Somnolence—Docetaxel—pancreatic cancer	1.4e-05	0.000262	CcSEcCtD
Pazopanib—Rash—Gemcitabine—pancreatic cancer	1.4e-05	0.000262	CcSEcCtD
Pazopanib—Dermatitis—Gemcitabine—pancreatic cancer	1.4e-05	0.000262	CcSEcCtD
Pazopanib—Eye disorder—Epirubicin—pancreatic cancer	1.39e-05	0.000261	CcSEcCtD
Pazopanib—Haemoglobin—Doxorubicin—pancreatic cancer	1.39e-05	0.00026	CcSEcCtD
Pazopanib—Headache—Gemcitabine—pancreatic cancer	1.39e-05	0.00026	CcSEcCtD
Pazopanib—Cardiac disorder—Epirubicin—pancreatic cancer	1.38e-05	0.00026	CcSEcCtD
Pazopanib—Flushing—Epirubicin—pancreatic cancer	1.38e-05	0.00026	CcSEcCtD
Pazopanib—Vomiting—Fluorouracil—pancreatic cancer	1.38e-05	0.00026	CcSEcCtD
Pazopanib—Dyspepsia—Docetaxel—pancreatic cancer	1.38e-05	0.000259	CcSEcCtD
Pazopanib—Haemorrhage—Doxorubicin—pancreatic cancer	1.38e-05	0.000259	CcSEcCtD
Pazopanib—Hypoaesthesia—Doxorubicin—pancreatic cancer	1.37e-05	0.000257	CcSEcCtD
Pazopanib—Rash—Fluorouracil—pancreatic cancer	1.37e-05	0.000257	CcSEcCtD
Pazopanib—Dermatitis—Fluorouracil—pancreatic cancer	1.37e-05	0.000257	CcSEcCtD
Pazopanib—Decreased appetite—Docetaxel—pancreatic cancer	1.37e-05	0.000256	CcSEcCtD
Pazopanib—Headache—Fluorouracil—pancreatic cancer	1.36e-05	0.000256	CcSEcCtD
Pazopanib—Urinary tract disorder—Doxorubicin—pancreatic cancer	1.36e-05	0.000256	CcSEcCtD
Pazopanib—Oedema peripheral—Doxorubicin—pancreatic cancer	1.36e-05	0.000255	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Docetaxel—pancreatic cancer	1.36e-05	0.000254	CcSEcCtD
Pazopanib—Connective tissue disorder—Doxorubicin—pancreatic cancer	1.36e-05	0.000254	CcSEcCtD
Pazopanib—Fatigue—Docetaxel—pancreatic cancer	1.36e-05	0.000254	CcSEcCtD
Pazopanib—Angiopathy—Epirubicin—pancreatic cancer	1.35e-05	0.000254	CcSEcCtD
Pazopanib—Urethral disorder—Doxorubicin—pancreatic cancer	1.35e-05	0.000254	CcSEcCtD
Pazopanib—Nausea—Irinotecan—pancreatic cancer	1.35e-05	0.000253	CcSEcCtD
Pazopanib—Mediastinal disorder—Epirubicin—pancreatic cancer	1.34e-05	0.000252	CcSEcCtD
Pazopanib—Pain—Docetaxel—pancreatic cancer	1.34e-05	0.000252	CcSEcCtD
Pazopanib—Chills—Epirubicin—pancreatic cancer	1.34e-05	0.000251	CcSEcCtD
Pazopanib—Alopecia—Epirubicin—pancreatic cancer	1.32e-05	0.000247	CcSEcCtD
Pazopanib—Nausea—Gemcitabine—pancreatic cancer	1.32e-05	0.000247	CcSEcCtD
Pazopanib—Mental disorder—Epirubicin—pancreatic cancer	1.31e-05	0.000245	CcSEcCtD
Pazopanib—Erythema—Epirubicin—pancreatic cancer	1.3e-05	0.000243	CcSEcCtD
Pazopanib—Malnutrition—Epirubicin—pancreatic cancer	1.3e-05	0.000243	CcSEcCtD
Pazopanib—Nausea—Fluorouracil—pancreatic cancer	1.29e-05	0.000242	CcSEcCtD
Pazopanib—Eye disorder—Doxorubicin—pancreatic cancer	1.29e-05	0.000242	CcSEcCtD
Pazopanib—Gastrointestinal pain—Docetaxel—pancreatic cancer	1.29e-05	0.000241	CcSEcCtD
Pazopanib—Flushing—Doxorubicin—pancreatic cancer	1.28e-05	0.00024	CcSEcCtD
Pazopanib—Cardiac disorder—Doxorubicin—pancreatic cancer	1.28e-05	0.00024	CcSEcCtD
Pazopanib—Flatulence—Epirubicin—pancreatic cancer	1.28e-05	0.00024	CcSEcCtD
Pazopanib—Dysgeusia—Epirubicin—pancreatic cancer	1.27e-05	0.000238	CcSEcCtD
Pazopanib—Angiopathy—Doxorubicin—pancreatic cancer	1.25e-05	0.000235	CcSEcCtD
Pazopanib—Muscle spasms—Epirubicin—pancreatic cancer	1.25e-05	0.000234	CcSEcCtD
Pazopanib—Mediastinal disorder—Doxorubicin—pancreatic cancer	1.24e-05	0.000233	CcSEcCtD
Pazopanib—Abdominal pain—Docetaxel—pancreatic cancer	1.24e-05	0.000233	CcSEcCtD
Pazopanib—Chills—Doxorubicin—pancreatic cancer	1.24e-05	0.000232	CcSEcCtD
Pazopanib—Vision blurred—Epirubicin—pancreatic cancer	1.22e-05	0.000229	CcSEcCtD
Pazopanib—Alopecia—Doxorubicin—pancreatic cancer	1.22e-05	0.000229	CcSEcCtD
Pazopanib—Mental disorder—Doxorubicin—pancreatic cancer	1.21e-05	0.000227	CcSEcCtD
Pazopanib—Erythema—Doxorubicin—pancreatic cancer	1.2e-05	0.000225	CcSEcCtD
Pazopanib—Malnutrition—Doxorubicin—pancreatic cancer	1.2e-05	0.000225	CcSEcCtD
Pazopanib—Anaemia—Epirubicin—pancreatic cancer	1.2e-05	0.000225	CcSEcCtD
Pazopanib—Flatulence—Doxorubicin—pancreatic cancer	1.18e-05	0.000222	CcSEcCtD
Pazopanib—Dysgeusia—Doxorubicin—pancreatic cancer	1.18e-05	0.000221	CcSEcCtD
Pazopanib—Syncope—Epirubicin—pancreatic cancer	1.16e-05	0.000218	CcSEcCtD
Pazopanib—Leukopenia—Epirubicin—pancreatic cancer	1.16e-05	0.000218	CcSEcCtD
Pazopanib—Muscle spasms—Doxorubicin—pancreatic cancer	1.16e-05	0.000217	CcSEcCtD
Pazopanib—Loss of consciousness—Epirubicin—pancreatic cancer	1.14e-05	0.000214	CcSEcCtD
Pazopanib—Cough—Epirubicin—pancreatic cancer	1.13e-05	0.000212	CcSEcCtD
Pazopanib—Vision blurred—Doxorubicin—pancreatic cancer	1.13e-05	0.000212	CcSEcCtD
Pazopanib—Asthenia—Docetaxel—pancreatic cancer	1.13e-05	0.000211	CcSEcCtD
Pazopanib—Hypertension—Epirubicin—pancreatic cancer	1.12e-05	0.00021	CcSEcCtD
Pazopanib—Pruritus—Docetaxel—pancreatic cancer	1.11e-05	0.000208	CcSEcCtD
Pazopanib—Anaemia—Doxorubicin—pancreatic cancer	1.11e-05	0.000208	CcSEcCtD
Pazopanib—Chest pain—Epirubicin—pancreatic cancer	1.11e-05	0.000207	CcSEcCtD
Pazopanib—Myalgia—Epirubicin—pancreatic cancer	1.11e-05	0.000207	CcSEcCtD
Pazopanib—Arthralgia—Epirubicin—pancreatic cancer	1.11e-05	0.000207	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.1e-05	0.000206	CcSEcCtD
Pazopanib—Dry mouth—Epirubicin—pancreatic cancer	1.08e-05	0.000203	CcSEcCtD
Pazopanib—Syncope—Doxorubicin—pancreatic cancer	1.08e-05	0.000202	CcSEcCtD
Pazopanib—Leukopenia—Doxorubicin—pancreatic cancer	1.08e-05	0.000202	CcSEcCtD
Pazopanib—Diarrhoea—Docetaxel—pancreatic cancer	1.08e-05	0.000202	CcSEcCtD
Pazopanib—Oedema—Epirubicin—pancreatic cancer	1.06e-05	0.000199	CcSEcCtD
Pazopanib—Loss of consciousness—Doxorubicin—pancreatic cancer	1.06e-05	0.000198	CcSEcCtD
Pazopanib—Infection—Epirubicin—pancreatic cancer	1.05e-05	0.000197	CcSEcCtD
Pazopanib—Cough—Doxorubicin—pancreatic cancer	1.05e-05	0.000197	CcSEcCtD
Pazopanib—Shock—Epirubicin—pancreatic cancer	1.04e-05	0.000195	CcSEcCtD
Pazopanib—Nervous system disorder—Epirubicin—pancreatic cancer	1.04e-05	0.000195	CcSEcCtD
Pazopanib—Dizziness—Docetaxel—pancreatic cancer	1.04e-05	0.000195	CcSEcCtD
Pazopanib—Thrombocytopenia—Epirubicin—pancreatic cancer	1.04e-05	0.000195	CcSEcCtD
Pazopanib—Hypertension—Doxorubicin—pancreatic cancer	1.04e-05	0.000195	CcSEcCtD
Pazopanib—Skin disorder—Epirubicin—pancreatic cancer	1.03e-05	0.000193	CcSEcCtD
Pazopanib—Hyperhidrosis—Epirubicin—pancreatic cancer	1.02e-05	0.000192	CcSEcCtD
Pazopanib—Myalgia—Doxorubicin—pancreatic cancer	1.02e-05	0.000192	CcSEcCtD
Pazopanib—Chest pain—Doxorubicin—pancreatic cancer	1.02e-05	0.000192	CcSEcCtD
Pazopanib—Arthralgia—Doxorubicin—pancreatic cancer	1.02e-05	0.000192	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.02e-05	0.00019	CcSEcCtD
Pazopanib—Anorexia—Epirubicin—pancreatic cancer	1.01e-05	0.000189	CcSEcCtD
Pazopanib—Dry mouth—Doxorubicin—pancreatic cancer	1e-05	0.000188	CcSEcCtD
Pazopanib—Vomiting—Docetaxel—pancreatic cancer	9.99e-06	0.000187	CcSEcCtD
Pazopanib—Rash—Docetaxel—pancreatic cancer	9.91e-06	0.000186	CcSEcCtD
Pazopanib—Dermatitis—Docetaxel—pancreatic cancer	9.9e-06	0.000186	CcSEcCtD
Pazopanib—Headache—Docetaxel—pancreatic cancer	9.85e-06	0.000185	CcSEcCtD
Pazopanib—Oedema—Doxorubicin—pancreatic cancer	9.81e-06	0.000184	CcSEcCtD
Pazopanib—Infection—Doxorubicin—pancreatic cancer	9.75e-06	0.000183	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	9.66e-06	0.000181	CcSEcCtD
Pazopanib—Shock—Doxorubicin—pancreatic cancer	9.65e-06	0.000181	CcSEcCtD
Pazopanib—Nervous system disorder—Doxorubicin—pancreatic cancer	9.62e-06	0.00018	CcSEcCtD
Pazopanib—Thrombocytopenia—Doxorubicin—pancreatic cancer	9.6e-06	0.00018	CcSEcCtD
Pazopanib—Insomnia—Epirubicin—pancreatic cancer	9.59e-06	0.00018	CcSEcCtD
Pazopanib—Skin disorder—Doxorubicin—pancreatic cancer	9.53e-06	0.000179	CcSEcCtD
Pazopanib—Paraesthesia—Epirubicin—pancreatic cancer	9.52e-06	0.000178	CcSEcCtD
Pazopanib—Hyperhidrosis—Doxorubicin—pancreatic cancer	9.48e-06	0.000178	CcSEcCtD
Pazopanib—Dyspnoea—Epirubicin—pancreatic cancer	9.45e-06	0.000177	CcSEcCtD
Pazopanib—Somnolence—Epirubicin—pancreatic cancer	9.43e-06	0.000177	CcSEcCtD
Pazopanib—Anorexia—Doxorubicin—pancreatic cancer	9.35e-06	0.000175	CcSEcCtD
Pazopanib—Nausea—Docetaxel—pancreatic cancer	9.34e-06	0.000175	CcSEcCtD
Pazopanib—Dyspepsia—Epirubicin—pancreatic cancer	9.33e-06	0.000175	CcSEcCtD
Pazopanib—Decreased appetite—Epirubicin—pancreatic cancer	9.22e-06	0.000173	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9.15e-06	0.000172	CcSEcCtD
Pazopanib—Fatigue—Epirubicin—pancreatic cancer	9.14e-06	0.000171	CcSEcCtD
Pazopanib—Pain—Epirubicin—pancreatic cancer	9.07e-06	0.00017	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.94e-06	0.000168	CcSEcCtD
Pazopanib—Insomnia—Doxorubicin—pancreatic cancer	8.87e-06	0.000166	CcSEcCtD
Pazopanib—Paraesthesia—Doxorubicin—pancreatic cancer	8.81e-06	0.000165	CcSEcCtD
Pazopanib—Dyspnoea—Doxorubicin—pancreatic cancer	8.75e-06	0.000164	CcSEcCtD
Pazopanib—Somnolence—Doxorubicin—pancreatic cancer	8.72e-06	0.000163	CcSEcCtD
Pazopanib—Gastrointestinal pain—Epirubicin—pancreatic cancer	8.67e-06	0.000162	CcSEcCtD
Pazopanib—Dyspepsia—Doxorubicin—pancreatic cancer	8.64e-06	0.000162	CcSEcCtD
Pazopanib—Decreased appetite—Doxorubicin—pancreatic cancer	8.53e-06	0.00016	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.47e-06	0.000159	CcSEcCtD
Pazopanib—Fatigue—Doxorubicin—pancreatic cancer	8.46e-06	0.000159	CcSEcCtD
Pazopanib—Pain—Doxorubicin—pancreatic cancer	8.39e-06	0.000157	CcSEcCtD
Pazopanib—Abdominal pain—Epirubicin—pancreatic cancer	8.38e-06	0.000157	CcSEcCtD
Pazopanib—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.02e-06	0.00015	CcSEcCtD
Pazopanib—Abdominal pain—Doxorubicin—pancreatic cancer	7.75e-06	0.000145	CcSEcCtD
Pazopanib—Asthenia—Epirubicin—pancreatic cancer	7.61e-06	0.000143	CcSEcCtD
Pazopanib—Pruritus—Epirubicin—pancreatic cancer	7.5e-06	0.000141	CcSEcCtD
Pazopanib—Diarrhoea—Epirubicin—pancreatic cancer	7.25e-06	0.000136	CcSEcCtD
Pazopanib—Asthenia—Doxorubicin—pancreatic cancer	7.04e-06	0.000132	CcSEcCtD
Pazopanib—Dizziness—Epirubicin—pancreatic cancer	7.01e-06	0.000131	CcSEcCtD
Pazopanib—Pruritus—Doxorubicin—pancreatic cancer	6.94e-06	0.00013	CcSEcCtD
Pazopanib—Vomiting—Epirubicin—pancreatic cancer	6.74e-06	0.000126	CcSEcCtD
Pazopanib—Diarrhoea—Doxorubicin—pancreatic cancer	6.71e-06	0.000126	CcSEcCtD
Pazopanib—Rash—Epirubicin—pancreatic cancer	6.68e-06	0.000125	CcSEcCtD
Pazopanib—Dermatitis—Epirubicin—pancreatic cancer	6.68e-06	0.000125	CcSEcCtD
Pazopanib—Headache—Epirubicin—pancreatic cancer	6.64e-06	0.000124	CcSEcCtD
Pazopanib—Dizziness—Doxorubicin—pancreatic cancer	6.49e-06	0.000122	CcSEcCtD
Pazopanib—Nausea—Epirubicin—pancreatic cancer	6.3e-06	0.000118	CcSEcCtD
Pazopanib—Vomiting—Doxorubicin—pancreatic cancer	6.24e-06	0.000117	CcSEcCtD
Pazopanib—Rash—Doxorubicin—pancreatic cancer	6.19e-06	0.000116	CcSEcCtD
Pazopanib—Dermatitis—Doxorubicin—pancreatic cancer	6.18e-06	0.000116	CcSEcCtD
Pazopanib—Headache—Doxorubicin—pancreatic cancer	6.15e-06	0.000115	CcSEcCtD
Pazopanib—Nausea—Doxorubicin—pancreatic cancer	5.83e-06	0.000109	CcSEcCtD
Pazopanib—PDGFRB—Signaling Pathways—PIK3CB—pancreatic cancer	5.53e-07	1.2e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CCND1—pancreatic cancer	5.51e-07	1.2e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	5.5e-07	1.19e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—SRC—pancreatic cancer	5.5e-07	1.19e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CCND1—pancreatic cancer	5.49e-07	1.19e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTEN—pancreatic cancer	5.47e-07	1.19e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CTNNB1—pancreatic cancer	5.45e-07	1.18e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CTNNB1—pancreatic cancer	5.44e-07	1.18e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.43e-07	1.18e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—STK11—pancreatic cancer	5.41e-07	1.17e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—HRAS—pancreatic cancer	5.41e-07	1.17e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PIK3CB—pancreatic cancer	5.41e-07	1.17e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HRAS—pancreatic cancer	5.37e-07	1.16e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—PIK3CA—pancreatic cancer	5.35e-07	1.16e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HRAS—pancreatic cancer	5.35e-07	1.16e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP9—pancreatic cancer	5.35e-07	1.16e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.34e-07	1.16e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PIK3CA—pancreatic cancer	5.34e-07	1.16e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP9—pancreatic cancer	5.33e-07	1.16e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PTEN—pancreatic cancer	5.32e-07	1.15e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—HRAS—pancreatic cancer	5.32e-07	1.15e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCL8—pancreatic cancer	5.31e-07	1.15e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—STAT3—pancreatic cancer	5.3e-07	1.15e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PTEN—pancreatic cancer	5.3e-07	1.15e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—KRAS—pancreatic cancer	5.29e-07	1.15e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—NRAS—pancreatic cancer	5.29e-07	1.15e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—SRC—pancreatic cancer	5.29e-07	1.15e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—KRAS—pancreatic cancer	5.24e-07	1.14e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTEN—pancreatic cancer	5.23e-07	1.14e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—PIK3CA—pancreatic cancer	5.23e-07	1.14e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—HRAS—pancreatic cancer	5.22e-07	1.13e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—PIK3CA—pancreatic cancer	5.21e-07	1.13e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCL8—pancreatic cancer	5.2e-07	1.13e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—SRC—pancreatic cancer	5.19e-07	1.13e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VEGFA—pancreatic cancer	5.15e-07	1.12e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PIK3CB—pancreatic cancer	5.14e-07	1.12e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—PIK3CA—pancreatic cancer	5.1e-07	1.11e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—STAT3—pancreatic cancer	5.1e-07	1.11e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—PIK3CA—pancreatic cancer	5.1e-07	1.11e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—pancreatic cancer	5.09e-07	1.11e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CD—pancreatic cancer	5.09e-07	1.1e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NRAS—pancreatic cancer	5.09e-07	1.1e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CD44—pancreatic cancer	5.09e-07	1.1e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CASP3—pancreatic cancer	5.08e-07	1.1e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—AKT1—pancreatic cancer	5.08e-07	1.1e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—SRC—pancreatic cancer	5.08e-07	1.1e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5.07e-07	1.1e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VEGFA—pancreatic cancer	5.06e-07	1.1e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—pancreatic cancer	5.06e-07	1.1e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—STAT3—pancreatic cancer	5.01e-07	1.09e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NRAS—pancreatic cancer	5e-07	1.08e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—AKT1—pancreatic cancer	4.99e-07	1.08e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.98e-07	1.08e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CASP3—pancreatic cancer	4.98e-07	1.08e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—HRAS—pancreatic cancer	4.95e-07	1.08e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCND1—pancreatic cancer	4.95e-07	1.07e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—HRAS—pancreatic cancer	4.94e-07	1.07e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TYMS—pancreatic cancer	4.94e-07	1.07e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.94e-07	1.07e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—pancreatic cancer	4.93e-07	1.07e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—SRC—pancreatic cancer	4.93e-07	1.07e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—SRC—pancreatic cancer	4.92e-07	1.07e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CTNNB1—pancreatic cancer	4.9e-07	1.06e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—STAT3—pancreatic cancer	4.9e-07	1.06e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NRAS—pancreatic cancer	4.88e-07	1.06e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GCG—pancreatic cancer	4.88e-07	1.06e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—PIK3CA—pancreatic cancer	4.86e-07	1.06e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCND1—pancreatic cancer	4.85e-07	1.05e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HRAS—pancreatic cancer	4.84e-07	1.05e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HRAS—pancreatic cancer	4.82e-07	1.05e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—EGFR—pancreatic cancer	4.82e-07	1.05e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PIK3CA—pancreatic cancer	4.81e-07	1.04e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—pancreatic cancer	4.8e-07	1.04e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VEGFA—pancreatic cancer	4.8e-07	1.04e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CTNNB1—pancreatic cancer	4.8e-07	1.04e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTEN—pancreatic cancer	4.8e-07	1.04e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VEGFA—pancreatic cancer	4.79e-07	1.04e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AKT1—pancreatic cancer	4.78e-07	1.04e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PTEN—pancreatic cancer	4.78e-07	1.04e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—STAT3—pancreatic cancer	4.75e-07	1.03e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NRAS—pancreatic cancer	4.74e-07	1.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—STAT3—pancreatic cancer	4.74e-07	1.03e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MYC—pancreatic cancer	4.74e-07	1.03e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—AKT1—pancreatic cancer	4.74e-07	1.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NRAS—pancreatic cancer	4.73e-07	1.03e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TGFB1—pancreatic cancer	4.73e-07	1.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—AKT1—pancreatic cancer	4.73e-07	1.03e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—HRAS—pancreatic cancer	4.72e-07	1.02e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HRAS—pancreatic cancer	4.71e-07	1.02e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—pancreatic cancer	4.7e-07	1.02e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—pancreatic cancer	4.7e-07	1.02e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—AKT1—pancreatic cancer	4.69e-07	1.02e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PTEN—pancreatic cancer	4.68e-07	1.02e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.66e-07	1.01e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MYC—pancreatic cancer	4.65e-07	1.01e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TGFB1—pancreatic cancer	4.64e-07	1.01e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EGFR—pancreatic cancer	4.64e-07	1.01e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOE—pancreatic cancer	4.61e-07	1e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—AKT1—pancreatic cancer	4.61e-07	1e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—STK11—pancreatic cancer	4.58e-07	9.95e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EGFR—pancreatic cancer	4.55e-07	9.88e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—KRAS—pancreatic cancer	4.55e-07	9.88e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—MYC—pancreatic cancer	4.55e-07	9.87e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—TGFB1—pancreatic cancer	4.54e-07	9.85e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HRAS—pancreatic cancer	4.5e-07	9.76e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—HRAS—pancreatic cancer	4.45e-07	9.66e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—EGFR—pancreatic cancer	4.45e-07	9.66e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTEN—pancreatic cancer	4.44e-07	9.64e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CB—pancreatic cancer	4.44e-07	9.63e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—SRC—pancreatic cancer	4.43e-07	9.62e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MYC—pancreatic cancer	4.42e-07	9.59e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TGFB1—pancreatic cancer	4.41e-07	9.57e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MYC—pancreatic cancer	4.41e-07	9.56e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TGFB1—pancreatic cancer	4.4e-07	9.54e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—KRAS—pancreatic cancer	4.38e-07	9.51e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—AKT1—pancreatic cancer	4.37e-07	9.5e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.37e-07	9.48e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—AKT1—pancreatic cancer	4.36e-07	9.47e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—SRC—pancreatic cancer	4.34e-07	9.41e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EGFR—pancreatic cancer	4.32e-07	9.38e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VEGFA—pancreatic cancer	4.31e-07	9.36e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EGFR—pancreatic cancer	4.31e-07	9.35e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.3e-07	9.34e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—KRAS—pancreatic cancer	4.3e-07	9.34e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—STAT3—pancreatic cancer	4.27e-07	9.27e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AKT1—pancreatic cancer	4.27e-07	9.27e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL8—pancreatic cancer	4.26e-07	9.25e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NRAS—pancreatic cancer	4.26e-07	9.25e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—AKT1—pancreatic cancer	4.26e-07	9.24e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VEGFA—pancreatic cancer	4.22e-07	9.17e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—KRAS—pancreatic cancer	4.2e-07	9.12e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—PIK3CA—pancreatic cancer	4.18e-07	9.08e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—STAT3—pancreatic cancer	4.18e-07	9.08e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NRAS—pancreatic cancer	4.17e-07	9.06e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—AKT1—pancreatic cancer	4.17e-07	9.05e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AKT1—pancreatic cancer	4.16e-07	9.04e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	4.16e-07	9.03e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—KRAS—pancreatic cancer	4.08e-07	8.86e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CASP3—pancreatic cancer	4.08e-07	8.86e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—KRAS—pancreatic cancer	4.07e-07	8.84e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PIK3CA—pancreatic cancer	4.02e-07	8.73e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOE—pancreatic cancer	4.02e-07	8.72e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.02e-07	8.72e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AKT1—pancreatic cancer	3.97e-07	8.62e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCND1—pancreatic cancer	3.97e-07	8.62e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MYC—pancreatic cancer	3.97e-07	8.62e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TGFB1—pancreatic cancer	3.96e-07	8.6e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PIK3CA—pancreatic cancer	3.95e-07	8.58e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TYMS—pancreatic cancer	3.94e-07	8.56e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CTNNB1—pancreatic cancer	3.93e-07	8.54e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—AKT1—pancreatic cancer	3.93e-07	8.53e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CD44—pancreatic cancer	3.93e-07	8.52e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—pancreatic cancer	3.89e-07	8.45e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MYC—pancreatic cancer	3.89e-07	8.44e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EGFR—pancreatic cancer	3.88e-07	8.43e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TGFB1—pancreatic cancer	3.88e-07	8.42e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—HRAS—pancreatic cancer	3.87e-07	8.4e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—PIK3CA—pancreatic cancer	3.86e-07	8.38e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—pancreatic cancer	3.86e-07	8.37e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PTEN—pancreatic cancer	3.83e-07	8.32e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—pancreatic cancer	3.82e-07	8.3e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EGFR—pancreatic cancer	3.8e-07	8.25e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOE—pancreatic cancer	3.79e-07	8.22e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GCG—pancreatic cancer	3.76e-07	8.17e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PIK3CA—pancreatic cancer	3.75e-07	8.14e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PIK3CA—pancreatic cancer	3.74e-07	8.12e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HRAS—pancreatic cancer	3.72e-07	8.08e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	3.69e-07	8.01e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—KRAS—pancreatic cancer	3.67e-07	7.96e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.66e-07	7.94e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HRAS—pancreatic cancer	3.66e-07	7.94e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—pancreatic cancer	3.63e-07	7.87e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.63e-07	7.87e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—pancreatic cancer	3.62e-07	7.85e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—KRAS—pancreatic cancer	3.59e-07	7.79e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—HRAS—pancreatic cancer	3.57e-07	7.76e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—SRC—pancreatic cancer	3.55e-07	7.72e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—STK11—pancreatic cancer	3.54e-07	7.68e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARG—pancreatic cancer	3.5e-07	7.6e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HRAS—pancreatic cancer	3.47e-07	7.53e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VEGFA—pancreatic cancer	3.46e-07	7.52e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HRAS—pancreatic cancer	3.46e-07	7.51e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—STAT3—pancreatic cancer	3.43e-07	7.44e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NRAS—pancreatic cancer	3.42e-07	7.42e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.42e-07	7.42e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—AKT1—pancreatic cancer	3.42e-07	7.42e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	3.38e-07	7.34e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PIK3CA—pancreatic cancer	3.37e-07	7.31e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PIK3CA—pancreatic cancer	3.3e-07	7.16e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.3e-07	7.16e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AKT1—pancreatic cancer	3.29e-07	7.13e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—pancreatic cancer	3.26e-07	7.08e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AKT1—pancreatic cancer	3.23e-07	7.01e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOE—pancreatic cancer	3.21e-07	6.96e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—pancreatic cancer	3.19e-07	6.93e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.19e-07	6.92e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.19e-07	6.92e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MYC—pancreatic cancer	3.19e-07	6.91e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TGFB1—pancreatic cancer	3.18e-07	6.9e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.16e-07	6.86e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—AKT1—pancreatic cancer	3.15e-07	6.85e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PIK3CA—pancreatic cancer	3.13e-07	6.8e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HRAS—pancreatic cancer	3.12e-07	6.77e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EGFR—pancreatic cancer	3.12e-07	6.76e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AKT1—pancreatic cancer	3.06e-07	6.65e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AKT1—pancreatic cancer	3.06e-07	6.63e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HRAS—pancreatic cancer	3.05e-07	6.63e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.04e-07	6.61e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.04e-07	6.59e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—AKT1—pancreatic cancer	3.02e-07	6.55e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3e-07	6.52e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—KRAS—pancreatic cancer	2.94e-07	6.39e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.89e-07	6.28e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.79e-07	6.06e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.78e-07	6.03e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—AKT1—pancreatic cancer	2.76e-07	6e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.76e-07	5.98e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.75e-07	5.98e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AKT1—pancreatic cancer	2.75e-07	5.98e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CA—pancreatic cancer	2.7e-07	5.87e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AKT1—pancreatic cancer	2.7e-07	5.85e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.62e-07	5.68e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—pancreatic cancer	2.62e-07	5.68e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.59e-07	5.63e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—AKT1—pancreatic cancer	2.56e-07	5.56e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.54e-07	5.52e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HRAS—pancreatic cancer	2.5e-07	5.43e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOE—pancreatic cancer	2.48e-07	5.37e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTEN—pancreatic cancer	2.4e-07	5.21e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.26e-07	4.91e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.23e-07	4.85e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.22e-07	4.81e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AKT1—pancreatic cancer	2.21e-07	4.8e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.2e-07	4.77e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.16e-07	4.68e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.96e-07	4.26e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.94e-07	4.22e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.92e-07	4.16e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.71e-07	3.72e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.7e-07	3.68e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.69e-07	3.68e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.6e-07	3.46e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.59e-07	3.45e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.48e-07	3.21e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AKT1—pancreatic cancer	1.38e-07	3e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.35e-07	2.94e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.3e-07	2.83e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.1e-07	2.4e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.04e-07	2.27e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.53e-08	1.85e-06	CbGpPWpGaD
